Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Flow cytometric test for beryllium sensitivity.

Tatyana N Milovanova1, Sicco H Popma, Sindhu Cherian

  • 1Pulmonary, Allergy and Critical Care Division, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania 19104, USA.

Cytometry. Part B, Clinical Cytometry
|June 29, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CD48 expression in T-lymphoblastic leukemia/lymphoma and mature T-cell neoplasms: role in detecting measurable residual disease and potential confounders, a single-institution retrospective review.

American journal of clinical pathology·2026
Same author

Troubleshooting Bacterial Contamination in a Diagnostic Flow Cytometry Laboratory: A Root Cause Analysis.

International journal of laboratory hematology·2026
Same author

Immunophenotypic abnormality quantification refines multiparameter flow cytometry-based measurable residual disease testing in adults allografted for acute myeloid leukemia in morphologic remission.

HemaSphere·2026
Same author

Clinical and translational results from a phase 1 trial of gemcitabine/nab-paclitaxel with nivolumab/ipilimumab or hydroxychloroquine/ipilimumab in untreated metastatic pancreatic adenocarcinoma.

Journal for immunotherapy of cancer·2026
Same author

The Secretome of Human Trophoblast Stem Cells Attenuates Senescence-Associated Traits.

Aging cell·2026
Same author

MRD assessment by flow cytometry in B-ALL made easier.

Blood advances·2025
Same journal

What is the optimal threshold for aberrant lymphoblasts at diagnosis to predict lymphoid transformation in chronic myeloid leukemia?

Cytometry. Part B, Clinical cytometry·2026
Same journal

Quantifying interpretive contributions to analytical variability in clinical flow cytometry.

Cytometry. Part B, Clinical cytometry·2026
Same journal

Quantifying gating heterogeneity in the Ogata score: Implications for reproducibility and score-based diagnostics.

Cytometry. Part B, Clinical cytometry·2026
Same journal

DinoFlow: Self-supervised pretraining in flow cytometry enables accurate detection of common hematopathological disorders.

Cytometry. Part B, Clinical cytometry·2026
Same journal

Flow cytometric PD-L1 expression enhances identification of Reed-Sternberg cells in suspected Hodgkin lymphoma from lymph node biopsies.

Cytometry. Part B, Clinical cytometry·2026
Same journal

27-color flow cytometry for measurable residual disease detection in B-cell lymphoblastic leukemia.

Cytometry. Part B, Clinical cytometry·2026
See all related articles

A new flow cytometry method offers a sensitive, nonradioactive way to detect beryllium hypersensitivity in Chronic Beryllium Disease (CBD). This technique identifies specific T-cell responses, improving diagnostic accuracy and standardization for clinical use.

Area of Science:

  • Immunology
  • Occupational Health
  • Flow Cytometry

Background:

  • Chronic Beryllium Disease (CBD) is a lung disorder caused by beryllium hypersensitivity mediated by CD4+ T cells.
  • Current diagnostic tests for CBD use radioactive 3H thymidine incorporation, facing issues with variability and radioactivity.
  • There is a need for alternative, nonradioactive methods for diagnosing and monitoring CBD.

Purpose of the Study:

  • To evaluate a novel 5,6-carboxyfluorescein diacetate succinimidyl ester flow cytometry technique for measuring T-lymphocyte proliferation in response to beryllium.
  • To compare the new method with traditional proliferation tests for sensitivity and specificity.

Main Methods:

  • A flow cytometry technique using 5,6-carboxyfluorescein diacetate succinimidyl ester was applied.

Related Experiment Videos

  • T-lymphocyte proliferation was measured in response to mitogens and beryllium antigen.
  • Beryllium-exposed sensitized individuals and unexposed controls were studied.

    • Main Results:

    • The flow cytometry method detected T-lymphocyte proliferation in CD3+, CD4+, and CD8+ subpopulations.
    • Mitogens (Phytohemagglutinin, Candida) stimulated CD4+ and CD8+ T-cell responses.
    • Beryllium specifically stimulated CD3+/CD4+ T-cell responses.

    Conclusions:

    • The flow cytometry technique is a promising nonradioactive alternative for assessing beryllium sensitivity.
    • This method allows for phenotypic identification of responding T-cell types, enhancing specificity.
    • The technique may offer improved standardization for clinical application in CBD diagnosis and monitoring.